5 stories this morning, for surgeons and the people who support them.
- HHS OCR final rule, HIPAA Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens (RIN 0945-AA00; on public inspection Nov 16, publishes Nov 19): right-of-access response time cut to 15 calendar days from 30 (one 30-day extension retained); no fee for inspection or internet-based access; posted fee schedules; right to direct copies to a third party limited to electronic copies in an EHR; NPP written acknowledgment eliminated; minimum necessary exception and good faith standard not finalized; effective 60 days and compliance 240 days after publication — Federal Register public inspection document 2026-23429 (final rule, 45 CFR Parts 160 and 164), scheduled for publication 2026-11-19; finalizes the January 21, 2021 NPRM (86 FR 6446). Verified in rule text: access response 'no more than 15 calendar days after receipt of the request (reduced from the current 30 days)' with a 30-calendar-day extension retained; 164.524(c)(4)(ii) no fee when an individual inspects PHI or accesses ePHI 'using an internet-based method, such as a personal health application'; new 164.525 requires a covered entity that charges for copies to post a fee schedule on its website, if it has one, and make it available at the point of service and upon request; right of access to direct limited to electronic copies of PHI in an EHR, following Ciox Health, LLC v. Azar (D.D.C. 2020); written acknowledgment of NPP receipt eliminated and NPP content modified; proposed minimum necessary exception for care coordination and proposed good faith standard not finalized; effective 60 days after publication, compliance 240 days after publication (computed: July 17, 2027); qualifying existing business associate agreements deemed compliant until renewal or modification on or after the compliance date or January 18, 2028, whichever is earlier. Not previously covered. Source
- CMS notices set 2027 Medicare cost sharing (publish Nov 19): Part B deductible $292 (from $283), standard Part B premium $209.40 (from $202.90; +$6.50, +3.2%), Part A inpatient hospital deductible $1,776 (from $1,736), effective January 1, 2027 — CMS-8094-N (FR Doc. 2026-23601): 2027 standard Part B premium $209.40, '3.2 percent or $6.50 higher than the 2026 standard premium rate of $202.90'; Part B deductible $292.00, calculated from the 2026 deductible of $283.00. CMS-8092-N (FR Doc. 2026-23603, https://public-inspection.federalregister.gov/2026-23603.pdf): CY 2027 inpatient hospital deductible $1,776, from $1,736 in CY 2026. Both scheduled for Federal Register publication 2026-11-19, effective January 1, 2027. The lower CY 2027 physician fee schedule conversion factor was covered in the 2026-11-05 episode. Source
- JAMA Surgery (Stanford, online Nov 18): validation of computer-vision ambient documentation of OR timestamps using Aimbient (formerly Surgical Safety Technologies) across 14 operating rooms and one procedure room over eight months; no statistically significant difference in accuracy versus manual entry across seven surgical service types, per the company's summary — Nobuhara CK, et al. Validation of Computer Vision in the Operating Room for Ambient Documentation. JAMA Surg, online Nov 18, 2026, doi 10.1001/jamasurg.2026.5500 (PubMed lists no abstract; plain language summary: 'validate ambient timestamp documentation for a variety of procedures in the operating room'). Study details come from Aimbient's Nov 18 release (https://www.prnewswire.com/news-releases/aimbient-ai-automates-or-documentation-across-specialties-with-human-level-accuracy-study-in-jama-surgery-finds-302944097.html) and are attributed to the company in the copy: 14 ORs and one procedure room at Stanford Health Care, eight months, patient-in and patient-out timestamps, blinded human video review as ground truth, no statistically significant difference versus manual documentation across seven service types, human accuracy degraded overnight and in long transplant cases, manual timestamps lag by five to six minutes on average, platform deployed in 650 rooms. Not previously covered. Source
- J Arthroplasty (USC, online Nov 16): in 1,483,703 primary hip and knee arthroplasties (2016-2023), high-dose day-of-surgery dexamethasone (16-32 mg; 8.8% of patients) was not associated with higher 90-day PJI versus none (TKA aOR 0.93, 95% CI 0.79-1.09; THA aOR 0.82, 0.68-1.00); low and medium doses likewise; findings held in diabetic patients — Telang SS, et al. (Keck School of Medicine of USC). National healthcare database; dose groups none 41.7%, low (4-5 mg) 17.1%, medium (8-12 mg) 32.5%, high (16-32 mg) 8.8%; primary outcome 90-day PJI by mixed-effect logistic regression with no-dexamethasone as reference, in diabetic and non-diabetic patients. Authors conclude higher doses 'appear safe in medically optimized patients undergoing TKA and THA'. The abstract reports no glucose outcomes. Not previously covered. Source
- J Orthop Trauma (online Nov 17): TriNetX propensity-matched study of tibial plateau fractures at age 55+ (2005-2020; 1,321 per arm): 5-year revision 7.0% after acute TKA vs 0.8% conversion to TKA after ORIF (RR 8.36); PJI 6.2% vs 1.3%; return to OR 25.6% vs 23.5% (NS); acute vs conversion TKA revision 9.0% vs 10.0% (NS); acute TKA vs primary TKA for OA 7.4% vs 3.5% — Wahid M, et al. Retrospective cohort, TriNetX United States Collaborative Network, patients 55 and older, three 1:1 propensity-matched comparisons. Primary outcome revision at 5 years, defined as conversion to TKA after ORIF and revision TKA after arthroplasty. In ages 55-70, revision 9.3% vs 1.7%; not reportable at 70 and older owing to small cell counts. Authors conclude acute TKA 'should be reserved for patients at highest risk of ORIF failure requiring subsequent conversion to TKA'. Level III. Not previously covered. Source
Contribute to the Brief
Faculty can send the show a note — a reaction to a paper, a correction, a read on a rule change — either written, which we shape for broadcast and read in the show's voice, or as a voice note under three minutes, which airs in your own voice. Send one from Studio.
Not on doc social yet? Contribute a lecture or join the network — doc social is a clinical education platform for clinicians, and this show is one part of it.
Narration is synthesized. Reporting and editorial judgement are ours, and every story above links to its source.


